Cheung YM, Cromwell GE, Tolaney SM, Min L, et al. Factors leading to alpelisib discontinuation in patients with hormone receptor positive, human epidermal growth factor receptor-2 negative breast cancer. Breast Cancer Res Treat 2022 Jan 9. pii: 10.1007/s10549-021-06476.
PMID: 35000092